Cargando…

Early identification of LHON carriers may improve outcome

Detalles Bibliográficos
Autor principal:	Finsterer, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Romanian Society of Ophthalmology 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531766/ https://www.ncbi.nlm.nih.gov/pubmed/31198904

Ejemplares similares

Variable response to Idebenone in LHON is multifactorial
por: Finsterer, Josef, et al.
Publicado: (2023)

LHON needs to be genetically diagnosed and the idebenone effect quantified
por: Finsterer, Josef, et al.
Publicado: (2019)

Heteroplasmy Rates of the m.14495A>G variant in MT-ND6 May Not Predict the Phenotype of LHON
por: Finsterer, Josef, et al.
Publicado: (2019)

LHON Plus Due to the Variant m.3460G > A Requires Extensive Investigation and Close Monitoring
por: Finsterer, Josef, et al.
Publicado: (2022)

Antiepileptic treatment may determine the outcome of FARS2 mutation carriers
por: Finsterer, Josef, et al.
Publicado: (2018)

Pulmonary hypertension may be secondary in carriers of compound heterozygous FOXRED1 variants
por: Finsterer, Josef
Publicado: (2019)

Kidney transplantation in m.3243A>G carriers has outcome implications
por: Finsterer, Josef
Publicado: (2020)

Ketogenic diet in ATAD3A mutation carriers may not improve cerebellar atrophy but some clinical features [Letter]
por: Finsterer, Josef
Publicado: (2019)

Management of manifesting FOXRED1 carriers is complex
por: Finsterer, Josef, et al.
Publicado: (2019)

Early diagnosis and treatment of SARS-CoV-2 vaccination associated polyradiculitis improves outcome
por: Finsterer, Josef, et al.
Publicado: (2022)

Early diagnosis and treatment of SARS-CoV-2 vaccination associated polyradiculitis improves outcome
por: Finsterer, Josef, et al.
Publicado: (2022)

ADVERSE REACTION TO ANESTHESIA IN A M.8993T>C CARRIER WITH LEIGH SYNDROME
por: Finsterer, Josef
Publicado: (2019)

Caution When Using Valproate for Seizures in POLG1 Carriers
por: Mehri, Sounira, et al.
Publicado: (2023)

Antiepileptics and NO-precursors may be beneficial for stroke-like episodes
por: Finsterer, Josef
Publicado: (2018)

Doping May Be Responsible forDe Novo Mitochondrial Disorder
por: Finsterer, Josef
Publicado: (2019)

Carriers of POLG1 variants require investigations for multisystem disease and for mtDNA variations
por: Finsterer, Josef, et al.
Publicado: (2022)

Pathogenicity of the m.1630A > G variant remains elusive if related mutation carriers with similar heteroplasmy rates are asymptomatic
por: Finsterer, Josef
Publicado: (2019)

Dilative arteriopathy in Pompe disease may not only affect the cerebral arteries
por: Finsterer, Josef
Publicado: (2018)

Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers
por: Bianco, Angelica, et al.
Publicado: (2018)

Intra-familial phenotypic heterogeneity of m.3243A > G carriers remains elusive as long as heteroplasmy and mtDNA copy numbers are absent
por: Finsterer, Josef
Publicado: (2023)

Cerebellar stroke-like lesions in Leigh syndrome may mimic cerebellar cortical bleeding
por: Finsterer, Josef
Publicado: (2020)

Unvaccinated patients may still experience SARS-CoV-2 associated polyradiculitis
por: Finsterer, Josef
Publicado: (2022)

Metabolomics by magnetic resonance spectroscopy may not sufficiently explain “brain fog” in neuro-COVID
por: Finsterer, Josef
Publicado: (2022)

SARS-CoV-2 as Well as Anti-COVID-19 Treatment May Cause Rhabdomyolysis
por: Finsterer, Josef
Publicado: (2021)

Specification of the Myopathy Type may Influence the Management of Noncompaction
por: Finsterer, Josef, et al.
Publicado: (2016)

Stroke-like episodes in coenzyme-Q deficiency may respond to NO-precursors and non-mitochondrion-toxic antiepileptic drugs
por: Finsterer, Josef
Publicado: (2018)

Stroke-like episodes in coenzyme-Q deficiency may respond to NO-precursors and non-mitochondrion-toxic antiepileptic drugs
por: Finsterer, Josef
Publicado: (2018)

SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy
por: Finsterer, Josef
Publicado: (2021)

Frequency of new seizures after SARS-CoV-2 infections may depend on the length of follow-up
por: Finsterer, Josef
Publicado: (2023)

Even after the fourth dose of a SARS-CoV-2 vaccine neurological complications may develop
por: Finsterer, Josef
Publicado: (2023)

Mitochondrial DNA Haplogroup Background Affects LHON, but Not Suspected LHON, in Chinese Patients
por: Zhang, A-Mei, et al.
Publicado: (2011)

SARS-CoV-2 may unravel metabolic myopathy mistaken for myasthenia
por: Finsterer, Josef, et al.
Publicado: (2021)

Whole exome sequencing may be insufficient to cover the causality spectrum of rhabdomyolysis
por: Finsterer, Josef, et al.
Publicado: (2018)

SARS-CoV-2 associated polyradiculitis and myocarditis may favour Takotsubo syndrome
por: Finsterer, Josef, et al.
Publicado: (2021)

Heteroplasmy of the m.3243A>G Mutation May Influence Phenotypic Heterogeneity
por: Finsterer, Josef, et al.
Publicado: (2017)

LHON: Mitochondrial Mutations and More
por: Kirches, E
Publicado: (2011)

Suspect MELAS early to prevent unnecessary costs and burdens for the affected
por: Finsterer, Josef
Publicado: (2021)

Myotoxic drugs and immunodeficiency may contribute to the poor outcome of COVID-19 patients with myotonic dystrophy
por: Finsterer, J.
Publicado: (2020)

Letter to the Editor: Anti-SARS-CoV-2 Vaccination-Related Polyradiculitis Requires Early Diagnosis and Treatment to Improve the Outcome
por: Finsterer, Josef
Publicado: (2023)

Female and Male Carriers of TAZ Mutations Need To Be Thoroughly Investigated
por: Finsterer, J, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gs8jicrd4ft96ugkkr876on3ne